In this study, the aim is to verify, by immunohistochemistry, the expression of IGF1, MDM2, STAT1, and RAC1 and investigate their potential relationship with GCT recurrence, in a large cohort of patients with a giant cell tumor of the bone. Here, STAT1 is linked to granular cell tumor.